As of April 29, 2025, CASI Pharmaceuticals (CASI) has a market cap of $30.908 million USD. According to our data, CASI Pharmaceuticals is ranked No.8369 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $30.91 M |
-29.50%
|
Dec 31, 2024 | $43.84 M |
-60.47%
|
Dec 29, 2023 | $0.11 B |
300.00%
|
Dec 30, 2022 | $27.73 M |
-77.63%
|
Dec 31, 2021 | $0.12 B |
-72.88%
|
Dec 31, 2020 | $0.46 B |
-4.53%
|
Dec 31, 2019 | $0.48 B |
-23.13%
|
Dec 31, 2018 | $0.62 B |
23.69%
|
Dec 29, 2017 | $0.50 B |
182.61%
|
Dec 30, 2016 | $0.18 B |
19.79%
|
Dec 31, 2015 | $0.15 B |
-27.82%
|
Dec 31, 2014 | $0.21 B |
-20.36%
|
Dec 31, 2013 | $0.26 B |
21.01%
|
Dec 31, 2012 | $0.21 B |
45.26%
|
Dec 30, 2011 | $0.15 B |
-81.30%
|
Dec 31, 2010 | $0.79 B |
-42.27%
|
Dec 31, 2009 | $1.36 B |
400.00%
|
Dec 31, 2008 | $0.27 B |
-86.67%
|
Dec 31, 2007 | $2.05 B |
-24.05%
|
Dec 29, 2006 | $2.69 B |
-18.56%
|
Dec 30, 2005 | $3.31 B |
-40.12%
|
Dec 31, 2004 | $5.52 B |
-2.41%
|
Dec 31, 2003 | $5.66 B |
286.05%
|
Dec 31, 2002 | $1.47 B |
-89.82%
|
Dec 31, 2001 | $14.40 B |
-51.01%
|
Dec 29, 2000 | $29.40 B |
-32.68%
|
Dec 31, 1999 | $43.67 B |
22.02%
|
Dec 31, 1998 | $35.79 B |
85.64%
|
Dec 31, 1997 | $19.28 B |
-30.38%
|
Dec 31, 1996 | $27.69 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Karyopharm Therapeutics
KPTI
|
$54.42 M |
0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.88 B |
-0.000 M
|
![]() Canada
|
![]() Iovance Biotherapeutics
IOVA
|
$1.17 B |
0.000 M
|
![]() USA
|
![]() MacroGenics
MGNX
|
$0.10 B |
-0.000 M
|
![]() USA
|
![]() TG Therapeutics
TGTX
|
$6.89 B |
0.000 M
|
![]() USA
|
![]() Verastem Oncology
VSTM
|
$0.36 B |
-0.000 M
|
![]() USA
|
![]() G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
![]() USA
|
![]() Syndax Pharmaceuticals
SNDX
|
$1.18 B |
0.000 M
|
![]() USA
|
Market Cap | = | CASI Stock Price | * | CASI Shares Outstanding |
= | $2.00 | * | 15.49 M | |
= | $30.91 M |